As shown, NCOR1 was mutated in 3.76% of all breast tumors, and in 3.65% of basal-like, 2% of Luminal A, 2.45% of Luminal B, and 3.33% of HER2 positive (Fig 1C). The gene discussed is ERBB2; the disease is breast neoplasm.